Hanns Möhler

Affiliations: 
Institute of Pharmacology Universität Zürich, Zürich, ZH, Switzerland 
Google:
"Hanns Möhler"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Lüscher B, Möhler H. (2019) Brexanolone, a neurosteroid antidepressant, vindicates the GABAergic deficit hypothesis of depression and may foster resilience. F1000research. 8
Möhler H, Rudolph U. (2017) Disinhibition, an emerging pharmacology of learning and memory. F1000research. 6
Möhler H. (2015) The legacy of the benzodiazepine receptor: from flumazenil to enhancing cognition in Down syndrome and social interaction in autism. Advances in Pharmacology (San Diego, Calif.). 72: 1-36
Möhler H. (2014) Endogenous benzodiazepine site peptide ligands operating bidirectionally in vivo in neurogenesis and thalamic oscillations. Neurochemical Research. 39: 1032-6
Möhler H. (2012) Cognitive enhancement by pharmacological and behavioral interventions: the murine Down syndrome model. Biochemical Pharmacology. 84: 994-9
Möhler H. (2012) The GABA system in anxiety and depression and its therapeutic potential. Neuropharmacology. 62: 42-53
Möhler H. (2011) The rise of a new GABA pharmacology. Neuropharmacology. 60: 1042-9
Kopp S, Baur R, Sigel E, et al. (2010) Highly potent modulation of GABA(A) receptors by valerenic acid derivatives. Chemmedchem. 5: 678-81
Möhler H. (2009) Role of GABAA receptors in cognition. Biochemical Society Transactions. 37: 1328-33
Zeilhofer HU, Möhler H, Di Lio A. (2009) GABAergic analgesia: new insights from mutant mice and subtype-selective agonists. Trends in Pharmacological Sciences. 30: 397-402
See more...